Emily Campito, M.D,
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $638.86 | 40 | 91.8% |
| Education | $56.75 | 4 | 8.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $149.58 | 8 | $0 (2024) |
| PFIZER INC. | $61.30 | 5 | $0 (2023) |
| AMAG Pharmaceuticals, Inc. | $56.75 | 4 | $0 (2020) |
| Sumitomo Pharma America, Inc. | $48.99 | 3 | $0 (2024) |
| Allergan Inc. | $45.66 | 3 | $0 (2018) |
| Amgen Inc. | $42.64 | 3 | $0 (2018) |
| Myovant Sciences Inc. | $41.68 | 2 | $0 (2022) |
| Exeltis, USA Inc. | $31.93 | 2 | $0 (2024) |
| Lupin Inc. | $29.24 | 2 | $0 (2019) |
| MEDICEM INC. | $25.11 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $121.65 | 7 | Astellas Pharma US Inc ($38.67) |
| 2023 | $131.44 | 7 | Astellas Pharma US Inc ($57.80) |
| 2022 | $95.07 | 5 | Myovant Sciences Inc. ($41.68) |
| 2020 | $48.06 | 4 | Avion Pharmaceuticals ($13.54) |
| 2019 | $110.14 | 7 | Astellas Pharma US Inc ($37.59) |
| 2018 | $119.23 | 9 | Amgen Inc. ($29.94) |
| 2017 | $70.02 | 5 | Allergan Inc. ($32.51) |
All Payment Transactions
44 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: CONTRACEPTIVE | ||||||
| 11/06/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: HORMONE THERAPY | ||||||
| 08/28/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: CONTRACEPTIVE | ||||||
| 01/31/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: Biological | ||||||
| 01/29/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Biological | ||||||
| 01/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kyleena (Drug), Mirena, Skyla | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Womens Health | ||||||
| 01/16/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: HORMONE THERAPY | ||||||
| 11/28/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: HORMONE THERAPY | ||||||
| 06/14/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Biological | ||||||
| 06/07/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Biological | ||||||
| 05/17/2023 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $19.66 | General |
| 03/07/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: Urology | ||||||
| 02/09/2023 | MEDICEM INC. | DILAPAN-S (Device) | Food and Beverage | In-kind items and services | $25.11 | General |
| Category: SURGERY | ||||||
| 02/06/2023 | PFIZER INC. | PREMARIN (Drug), MYFEMBREE, PAXLOVID | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: WOMENS HEALTH | ||||||
| 12/21/2022 | Myovant Sciences Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: HORMONE THERAPY | ||||||
| 12/13/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Urology | ||||||
| 10/13/2022 | TherapeuticsMD, Inc. | ANNOVERA (Drug), IMVEXXY | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: OBSTETRICS GYNECOLOGY WOMEN'S HEALTH | ||||||
| 08/25/2022 | Myovant Sciences Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: HORMONE THERAPY | ||||||
| 08/23/2022 | MAYNE PHARMA INC. | — | Food and Beverage | In-kind items and services | $17.94 | General |
| 02/12/2020 | AMAG Pharmaceuticals, Inc. | VYLEESI (Drug), MAKENA, INTRAROSA | Education | In-kind items and services | $12.24 | General |
| Category: HYPOACTIVE SEXUAL DESIRE DISORDER HSDD | ||||||
| 02/06/2020 | Avion Pharmaceuticals | Balcoltra (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Oral Contraceptive | ||||||
| 01/30/2020 | AbbVie Inc. | ORILISSA (Drug) | Food and Beverage | In-kind items and services | $11.31 | General |
| Category: WOMENS HEALTH | ||||||
| 01/30/2020 | PFIZER INC. | PREMARIN (Drug) | Food and Beverage | In-kind items and services | $10.97 | General |
| Category: WOMENS HEALTH | ||||||
| 12/23/2019 | CooperSurgical, Inc. | Paragard (Device) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Endocrinology | ||||||
| 12/18/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 70 | 86 | $7,278 | $4,313 |
| 2022 | 2 | 66 | 79 | $6,731 | $4,116 |
| 2021 | 2 | 53 | 72 | $6,605 | $4,068 |
| 2020 | 3 | 69 | 76 | $5,109 | $2,890 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 30 | 46 | $5,198 | $2,824 | 54.3% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 40 | 40 | $2,080 | $1,489 | 71.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 30 | 43 | $4,859 | $2,752 | 56.6% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 36 | 36 | $1,872 | $1,364 | 72.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 28 | 47 | $5,311 | $3,099 | 58.4% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 25 | 25 | $1,294 | $968.50 | 74.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 23 | 30 | $3,354 | $1,547 | 46.1% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 33 | 33 | $1,625 | $1,298 | 79.9% |
| 81002 | Urinalysis, manual test | Office | 2020 | 13 | 13 | $130.00 | $44.89 | 34.5% |
About Emily Campito, M.D,
Emily Campito, M.D, is a Student in an Organized Health Care Education/Training Program healthcare provider based in Rochester, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/28/2010. The National Provider Identifier (NPI) number assigned to this provider is 1891012977.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Emily Campito, M.D, has received a total of $695.61 in payments from pharmaceutical and medical device companies, with $121.65 received in 2024. These payments were reported across 44 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($638.86).
As a Medicare-enrolled provider, Campito has provided services to 258 Medicare beneficiaries, totaling 313 services with total Medicare billing of $15,386. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Location Rochester, NY
- Active Since 04/28/2010
- Last Updated 04/28/2010
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1891012977
Products in Payments
- MYFEMBREE (Drug) $90.67
- Veozah (Drug) $73.04
- PREMARIN (Drug) $48.10
- Prolia (Biological) $42.64
- Myrbetriq (Drug) $38.95
- MYRBETRIQ (Drug) $37.59
- ESTRACE CREAM (Drug) $32.51
- SLYND (Drug) $31.93
- SOLOSEC (Drug) $29.24
- VYLEESI (Drug) $27.78
- DILAPAN-S (Device) $25.11
- NEXPLANON (Drug) $24.21
- ANNOVERA (Drug) $19.93
- Kyleena (Drug) $17.21
- Paragard (Device) $14.91
- MAKENA (Drug) $14.57
- Orilissa (Drug) $13.61
- Balcoltra (Drug) $13.54
- PVC (Drug) $13.20
- LO LOESTRIN FE (Drug) $13.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Rochester
Dr. Yucai Wang, Md, Phd, MD, PHD
Student in an Organized Health Care Education/Training Program — Payments: $1.1M
Kevin Perry, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $675,526
Arjun Sebastian, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $132,513
Benjamin Tracy
Student in an Organized Health Care Education/Training Program — Payments: $112,594
Dr. Vijay Agarwal, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $105,512
Mr. Timothy Brown, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $89,868